CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 2,685.6	$ 3,045.2
Short-term investments (Note 5)	1,156.4	930.7
Accounts receivable, net of allowances of $12.6 and $11.6, respectively	693.3	609.1
Other receivables	199.5	118.3
Inventories (Note 2)	1,140.9	1,086.7
Prepaid expenses	125.2	121.0
Other current assets	323.4	347.6
Current assets of discontinued operations (Note 4)	34.6	26.8
Total current assets	6,358.9	6,285.4
Long-term investments (Note 5)	274.7	307.9
Property, plant, and equipment, net	1,743.3	1,686.0
Operating lease right-of-use assets	96.5	98.2
Goodwill	1,768.5	1,776.7
Other intangible assets, net	1,130.8	1,176.6
Deferred income taxes	1,099.9	992.1
Other assets (Note 2)	784.8	721.6
Non-current assets of discontinued operations (Note 4)	14.8	10.8
Total assets	13,272.2	13,055.3
Current liabilities
Accounts payable	165.0	197.4
Accrued and other liabilities (Note 2)	1,393.9	1,282.4
Operating lease liabilities	26.8	23.4
Current liabilities of discontinued operations (Note 4)	2.3	2.0
Total current liabilities	1,588.0	1,505.2
Long-term debt	598.2	597.7
Operating lease liabilities	75.3	78.9
Uncertain tax positions	442.9	384.6
Other liabilities	362.6	426.0
Non-current liabilities of discontinued operations (Note 4)	0.2	0.0
Total liabilities	3,067.2	2,992.4
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	0.0	0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 658.2 and 654.8 shares issued, and 580.7 and 588.6 shares outstanding, respectively	658.2	654.8
Additional paid-in capital	2,697.4	2,613.4
Retained earnings	14,149.3	13,167.0
Accumulated other comprehensive loss (Note 12)	(250.4)	(244.5)
Treasury stock, at cost, 77.5 and 66.2 shares, respectively	(7,049.5)	(6,192.3)
Total Edwards Lifesciences Corporation stockholders' equity	10,205.0	9,998.4
Noncontrolling interest	0.0	64.5
Total stockholders' equity	10,205.0	10,062.9
Total liabilities and equity	$ 13,272.2	$ 13,055.3